Examkin

Question

Difficulty: MediumGastroenterology and Hepatology

A 45-year-old man is evaluated in the gastroenterology clinic for severe, recurrent upper abdominal pain and chronic diarrhea. Upper endoscopy performed last week revealed multiple prominent gastric folds and several large ulcers in the distal duodenum and proximal jejunum. The patient's presentation is highly suspicious for a gastrin-secreting neuroendocrine tumor (Zollinger-Ellison syndrome). His proton pump inhibitor therapy has been safely discontinued for an appropriate duration prior to testing. Arrange the following diagnostic steps in the most appropriate chronological order to definitively diagnose and localize this patient's suspected condition.

  1. 1Measure fasting serum gastrin concentration
  2. 2Evaluate gastric fluid pH
  3. 3Perform a secretin stimulation test
  4. 4Perform somatostatin receptor scintigraphy

Answer

The correct chronological sequence for evaluating suspected Zollinger-Ellison syndrome is: 1) Measure fasting serum gastrin concentration, 2) Evaluate gastric fluid pH, 3) Perform a secretin stimulation test, and 4) Perform somatostatin receptor scintigraphy.
The diagnostic algorithm for Zollinger-Ellison syndrome (ZES) requires establishing solid biochemical evidence of inappropriate gastrin secretion before utilizing resources to physically locate the tumor. The sequence begins with the best initial screening test, the fasting serum gastrin level. Because gastrin can be physiologically elevated in the setting of achlorhydria (e.g., autoimmune atrophic gastritis), a gastric pH must be checked next to confirm a highly acidic environment (pH < 2.0). If the gastrin level is elevated but not definitively diagnostic (> 1000 pg/mL is definitively diagnostic in the setting of pH < 2.0; however, most patients present with values between 110 and 1,000 pg/mL), a secretin stimulation test is performed to confirm the diagnosis. Once ZES is biochemically confirmed, tumor localization is pursued using somatostatin receptor scintigraphy or related functional imaging to guide surgical management.

Step-by-Step Solution

1
Measure fasting serum gastrin concentration
Identifies if the patient has hypergastrinemia.
This is the most sensitive and cost-effective initial screening test for a suspected gastrinoma.
2
Evaluate gastric fluid pH
Determines if the hypergastrinemia is appropriate or inappropriate.
A high gastrin level can be caused by achlorhydria (e.g., atrophic gastritis). A highly acidic pH (< 2.0) confirms that the hypergastrinemia is abnormal and autonomous.
3
Perform a secretin stimulation test
Biochemically confirms the diagnosis of Zollinger-Ellison syndrome.
Secretin normally inhibits gastrin release, but in patients with a gastrinoma, secretin paradoxically stimulates a massive release of gastrin. This is necessary when initial gastrin levels are elevated but not >1000 pg/mL.
4
Perform somatostatin receptor scintigraphy
Localizes the primary neuroendocrine tumor and any metastatic lesions.
Imaging is only performed after the biochemical diagnosis is secure, as gastrinomas are often small and difficult to detect, requiring targeted functional imaging.

Key Concept

The diagnostic algorithm for Zollinger-Ellison syndrome requires step-wise biochemical confirmation (gastrin level, then gastric pH, then secretin stimulation test) prior to attempting tumor localization with imaging.
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic